CELC Reports 48.9% ORR, 11.1-Month PFS, HR=0.50 in VIKTORIA-1 Breast Cancer Trial
Celcuity Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $132.88
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS